89 related articles for article (PubMed ID: 3045340)
1. Anal submucosal injection: a new route for drug administration in pelvic malignancies. II. Methotrexate anal injection in the treatment of advanced bladder cancer. Preliminary study.
Shafik A; Haddad S; Elwan F; el-Metnawi W; Olfat E
J Urol; 1988 Sep; 140(3):501-5. PubMed ID: 3045340
[TBL] [Abstract][Full Text] [Related]
2. Anal submucosal injection: a novel modality for the treatment of advanced rectal cancer.
Shafik A; El-Metnawy W; El-Sibai O
Eur J Surg Oncol; 1999 Feb; 25(1):76-81. PubMed ID: 10188860
[TBL] [Abstract][Full Text] [Related]
3. Anal submucosal injection: a new route for drug administration in pelvic malignancies. V. Advanced prostatic cancer: results of methotrexate treatment using the anal route--preliminary study.
Shafik A
Eur Urol; 1990; 18(2):132-6. PubMed ID: 2152339
[TBL] [Abstract][Full Text] [Related]
4. Anal submucosal injection: a new route for drug administration in pelvic malignancies. IV. Submucosal anal injection in the treatment of cancer of uterine cervix--preliminary study.
Shafik A
Am J Obstet Gynecol; 1989 Jul; 161(1):69-72. PubMed ID: 2750823
[TBL] [Abstract][Full Text] [Related]
5. [Experimental and clinical studies on anal submucosal injection of methotrexate for bladder cancer].
Yoshida T; Ogawa T; Fujinaga T; Kyoku I
Hinyokika Kiyo; 1991 Aug; 37(8):857-61. PubMed ID: 1957728
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
Kuroiwa T; Naito S; Hasuo K; Kishikawa T; Masuda K; Kumazawa J
Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced bladder cancer by submucosal injection of methotrexate in the anorectal area.
Damyanov C; Tonchev Z; Pavlova N; Ivanov A
Eur Urol; 1992; 21(3):211-5. PubMed ID: 1499627
[TBL] [Abstract][Full Text] [Related]
8. Anal submucosal injection: methotrexate concentration in rectal tumor tissue and serum after anal compared with parenteral injection.
Shafik A; el Dawi M; el-Metnawy W
Anticancer Drugs; 1994 Dec; 5(6):650-4. PubMed ID: 7888703
[TBL] [Abstract][Full Text] [Related]
9. Oral methotrexate for superficial transitional cell carcinoma of the bladder.
Olver IN; Sandeman TF; Laidlaw CR; Zimet AS; Bishop JF
J Urol; 1993 May; 149(5):1006-9. PubMed ID: 8483200
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
Boccardo F; Pace M; Guarneri D; Canobbio L; Curotto A; Martorana G
Cancer; 1994 Apr; 73(7):1932-6. PubMed ID: 8137220
[TBL] [Abstract][Full Text] [Related]
11. Intra- and perivesical tumor growth in preoperative staging of bladder cancer: the role of transrectal ultrasonography and high resolution magnetic resonance imaging.
Ruether U; Guhl L; Schmidt A; Stilz S; Bader H; Nunnensiek C; Rassweiler J; Eisenberger F; Jipp P
Urol Int; 1993; 50(3):141-7. PubMed ID: 8465480
[TBL] [Abstract][Full Text] [Related]
12. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
14. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.
Small EJ; Fippin LJ; Ernest ML; Carroll PR
Cancer; 1996 Oct; 78(8):1775-80. PubMed ID: 8859191
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for superficial bladder cancer.
Hall RR
Prog Clin Biol Res; 1985; 185B():143-9. PubMed ID: 3898139
[No Abstract] [Full Text] [Related]
17. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
Tsujino S; Ito T; Aizawa T; Namiki K; Ohno Y; Yamamoto S; Ishibashi K; Miki M; Yamauchi T; Kawai T
Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder.
Stoter G; Splinter TA; Child JA; Fosså SD; Denis L; van Oosterom AT; de Pauw M; Sylvester R
J Urol; 1987 Apr; 137(4):663-7. PubMed ID: 3560318
[TBL] [Abstract][Full Text] [Related]
19. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
de la Rosa F; Garcia-Carbonero R; Passas J; Rosino A; Lianes P; Paz-Ares L
J Urol; 2002 Jun; 167(6):2413-8. PubMed ID: 11992048
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic oral methotrexate therapy for multiple superficial bladder carcinoma.
Hall RR; Herring DW; Gibb I; Heath AB
Br J Urol; 1981 Dec; 53(6):582-4. PubMed ID: 7317746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
